Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

14 trials with published results (14%)

Research Maturity

57 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.0%

2 terminated out of 99 trials

Success Rate

96.6%

+10.1% vs benchmark

Late-Stage Pipeline

21%

21 trials in Phase 3/4

Results Transparency

25%

14 of 57 completed with results

Key Signals

14 with results97% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (21)
Early P 1 (2)
P 1 (6)
P 2 (4)
P 3 (7)
P 4 (14)

Trial Status

Completed57
Unknown20
Recruiting11
Withdrawn4
Not Yet Recruiting3
Terminated2

Trial Success Rate

96.6%

Benchmark: 86.5%

Based on 57 completed trials

Clinical Trials (99)

Showing 20 of 20 trials
NCT00156767CompletedPrimary

Adrenal Function in Critical Illness

NCT06955286Recruiting

Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion

NCT02769975RecruitingPrimary

Evaluation of Children With Endocrine and Metabolic-Related Conditions

NCT05435781Phase 4RecruitingPrimary

Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency

NCT05149638Not ApplicableRecruitingPrimary

Updated Diagnostic Cortisol Values for Adrenal Insufficiency

NCT06608433Not ApplicableCompleted

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

NCT05193396Phase 4RecruitingPrimary

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

NCT04519580Active Not Recruiting

Improved Diagnostics and Monitoring of Polymyalgia Rheumatica

NCT07168122Recruiting

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

NCT06430528Recruiting

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

NCT06980753Not ApplicableNot Yet Recruiting

Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT06861530RecruitingPrimary

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

NCT04642391Completed

Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis

NCT06637722Active Not RecruitingPrimary

Self-management in Patients With Adrenal Insufficiency.

NCT06435481Phase 4Not Yet RecruitingPrimary

Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics

NCT03294876Completed

Rheumatoid Arthritis Adrenal Recovery Study

NCT05716607Not ApplicableNot Yet Recruiting

Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

NCT06309498RecruitingPrimary

Residual Adrenal Function in Addison's Disease

NCT02818660Not ApplicableCompletedPrimary

Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests

Scroll to load more

Research Network

Activity Timeline